These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4338472)

  • 1. Enhancement of cardiovascular effects of glucagon by aminophylline.
    Afonso S; Hansing CE; Ansfield TJ; Berndt TB; Rowe GG
    Cardiovasc Res; 1972 May; 6(3):235-9. PubMed ID: 4338472
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular effects of glucagon in man.
    Klein SW; Morch JE; Mahon WA
    Can Med Assoc J; 1968 Jun; 98(25):1161-4. PubMed ID: 5657181
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon infusion following phosphodiesterase inhibition: an experimental study of the hemodynamic effects.
    Mitts TF; Jolley WB; Smith LL
    Arch Surg; 1973 Jul; 107(1):12-5. PubMed ID: 4351677
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular function and halothane.
    Goldberg AH
    Clin Anesth; 1968; 1():23-60. PubMed ID: 4877407
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic effects of low-dose isoproterenol and aminophylline after coronary embolization in dogs.
    Falicov RE; Lipp H; Resnekov L; King S
    Cardiovasc Res; 1973 Jan; 7(1):63-8. PubMed ID: 4694958
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of glucagon in the intact anesthetized and hepatectomized dog.
    Pappas G; Guillen J; Aldrete JA
    Surgery; 1970 Aug; 68(2):363-8. PubMed ID: 5450717
    [No Abstract]   [Full Text] [Related]  

  • 8. Responses to exogenous adenosine 3',5'-monophosphate of cardiac output and blood flow in the renal, superior mesenteric and carotid arteries in anesthetized dogs.
    Nozaki H; Okuaki A
    Tohoku J Exp Med; 1974 Feb; 112(2):119-28. PubMed ID: 4365154
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of glucagon following cardiac surgery.
    Vaughn CC; Warner HR; Nelson RM
    Surgery; 1970 Jan; 67(1):204-11. PubMed ID: 5409857
    [No Abstract]   [Full Text] [Related]  

  • 10. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification in dogs of the systemic and coronary hemodynamic effects of glucagon by sotalol.
    Berndt TB; Ansfield TJ; Alfonso S; Rowe GG
    Am Heart J; 1973 May; 85(5):671-8. PubMed ID: 4697635
    [No Abstract]   [Full Text] [Related]  

  • 12. Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog.
    Hopkins BE; Taylor RR
    J Clin Invest; 1974 Jun; 53(6):1716-25. PubMed ID: 4830233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of glucagon in myocardial infarction--effects on hemodynamics in experimental myocardial infarct in the dog].
    Matsuura Y; Tamura M; Kato K
    Jpn Circ J; 1973 Jul; 37(7):850-6. PubMed ID: 4800422
    [No Abstract]   [Full Text] [Related]  

  • 14. A role for glucagon in cardiac therapy.
    Parmley WW; Sonnenblick EH
    Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of glucagon in man.
    Parmley WW; Glick G; Sonnenblick EH
    N Engl J Med; 1968 Jul; 279(1):12-7. PubMed ID: 4872564
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of prostaglandin F2alpha administration prior to coronary ligation.
    Goldfarb RD; Mustafa SJ; Genn TM
    Am J Physiol; 1978 Jun; 234(6):H718-23. PubMed ID: 208420
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of Cassella 7657 and its interaction with adenosine, NAD and aminophylline in dogs.
    Afonso S; Hansing CE; Rowe GG
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):299-310. PubMed ID: 4360340
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
    Côté P; Polumbo RA; Harrison DC
    Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of glucagon infusion on cardiovascular function in the critically ill.
    Siegel JH; Levine MJ; McConn R; del Guercio LR
    Surg Gynecol Obstet; 1970 Sep; 131(3):505-15. PubMed ID: 5454535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.